CVE-2001-1116

Description

Identix BioLogon 2.03 and earlier does not lock secondary displays on a multi-monitor system running Windows 98 or ME, which allows an attacker with physical access to the system to bypass authentication through a secondary display.

4.6

CVSS

Severity: Medium

CVSS 2.0 •

EPSS 0.10%

Vendor Advisory ntadvice.com Vendor Advisory securityfocus.com

Affected: n/a n/a

References

Link	Tags
https://exchange.xforce.ibmcloud.com/vulnerabilities/6948	vdb entry
http://ntbugtraq.ntadvice.com/default.asp?pid=36&sid=1&A2=IND0108&L=NTBUGTRAQ&F=P&S=&P=71	mailing list vendor advisory
http://www.osvdb.org/5453	vdb entry
http://www.securityfocus.com/bid/3140	vdb entry vendor advisory
http://ntbugtraq.ntadvice.com/default.asp?pid=36&sid=1&A2=ind0108&L=ntbugtraq&F=P&S=&P=724	mailing list

Frequently Asked Questions

What is the severity of CVE-2001-1116?: CVE-2001-1116 has been scored as a medium severity vulnerability.
How to fix CVE-2001-1116?: To fix CVE-2001-1116, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2001-1116 being actively exploited in the wild?: As for now, there are no information to confirm that CVE-2001-1116 is being actively exploited. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.

This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.